Hematology

  1. Timing of convalescent plasma administration and 28-day mortality in COVID-19 pneumonia

    1. Soledad E González
    2. Lorena Regairaz
    3. Martin R Salazar
    4. Noelia S Ferrando
    5. Verónica V González Martínez
    6. Patricia M Carrera Ramos
    7. Santiago A Pesci
    8. Juan M Vidal
    9. Nicolás Kreplak
    10. Elisa Estenssoro

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  2. Mortality, critical illness, and mechanical ventilation among hospitalized patients with COVID-19 on therapeutic anticoagulants

    1. Niti G. Patel
    2. Ajay Bhasin
    3. Joseph M. Feinglass
    4. Michael P. Angarone
    5. Elaine R. Cohen
    6. Jeffrey H. Barsuk

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  3. Red Blood Cell Distribution Width in Hospitalized COVID-19 Patients

    1. Preethi Ramachandran
    2. Mahesh Gajendran
    3. Abhilash Perisetti
    4. Karim Osama Elkholy
    5. Abhishek Chakraborti
    6. Giuseppe Lippi
    7. Hemant Goyal

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  4. The association between ABO blood group and SARS-CoV-2 infection: A meta-analysis

    1. Davide Golinelli
    2. Erik Boetto
    3. Elisa Maietti
    4. Maria Pia Fantini

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  5. In-depth analysis of laboratory parameters reveals the interplay between sex, age, and systemic inflammation in individuals with COVID-19

    1. Felipe ten-Caten
    2. Patrícia Gonzalez-Dias
    3. Ícaro Castro
    4. Rodrigo L.T. Ogava
    5. Jeevan Giddaluru
    6. Juan Carlo S. Silva
    7. Felipe Martins
    8. André N.A. Gonçalves
    9. André G. Costa-Martins
    10. José D. Araujo
    11. Ana Carolina Viegas
    12. Fernando Q. Cunha
    13. Sandra Farsky
    14. Fernando A. Bozza
    15. Anna S. Levin
    16. Pia S. Pannaraj
    17. Thushan I. de Silva
    18. Paola Minoprio
    19. Fabiano Pinheiro da Silva
    20. Bruno B. Andrade
    21. Helder I. Nakaya

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  6. Use of Convalescent Plasma Therapy among Hospitalized Coronavirus Disease 2019 (COVID-19) Patients: A Single-Center Experience

    1. Flordeluna Z. Mesina
    2. Claudette G. Mangahas
    3. Ellen M. Gatchalian
    4. Mary Sheila Ariola-Ramos
    5. Rosalio P. Torres

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  7. High levels of plasminogen activator inhibitor-1, tissue plasminogen activator and fibrinogen in patients with severe COVID-19

    1. David Cabrera-Garcia
    2. Andrea Miltiades
    3. Samantha Parsons
    4. Katerina Elisman
    5. Mohammad Taghi Mansouri
    6. Gebhard Wagener
    7. Neil L. Harrison

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  8. Joint CBC-ICT Interpretation for the pre-surgical screening of COVID 19 asymptomatic cases: A cross-sectional study

    1. Tanzeel Imran
    2. Humera Altaf Naz
    3. Hamza Khan
    4. Ali Haider Bangash
    5. Laraib Bakhtiar Khan
    6. Haroon Khan

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  9. SARS-CoV-2 antibody responses in patients with aggressive haematological malignancies

    1. J. O’Nions
    2. L. Muir
    3. J. Zheng
    4. C. Rees-Spear
    5. A. Rosa
    6. C. Earl
    7. P. Cherepanov
    8. R. Gupta
    9. A. Khwaja
    10. C. Jolly
    11. L.E. McCoy

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  10. Impact of stopping therapy during the SARS-CoV-2 pandemic in persons with lymphoma

    1. Shenmiao Yang
    2. Dong Dong
    3. Hongfei Gu
    4. Robert Peter Gale
    5. Jun Ma
    6. Xiaojun Huang

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity
Previous Page 6 of 8 Next